Cholesterol, triglycerides, HDL, and nitric oxide as determinants of resting heart rate variability in non-hospitalized mild post-COVID individuals: a cross-sectional study.

Publication date: Jan 31, 2025

The association between plasma lipids, nitric oxide (NO) and cardiovascular risk has been well documented in the literature, however, the association between these outcomes and heart rate variability (HRV) in COVID-19 remains incipient as there is no scientific evidence that has investigated this outcome. Investigate whether metabolic outcomes may be associated with cardiac autonomic behavior arising from short-term HRV variables in non-hospitalized mild post-COVID individuals. This is a cross-sectional study. Individuals of both sexes, aged ≥ 18 years, who tested positive for SARS-CoV-2 according to the RT-PCR test, without the need for hospitalization, were included. The HRV was collected in the supine position for at least 10 min for later analysis in the Kubios software. Metabolic outcomes [high density lipoprotein (HDL) (mg/dL), cholesterol (mg/dL), triglycerides (mg/dL) and NO (umol/L)] were collected through a blood sample. Seventy-three individuals were included (post-COVID = 32; control = 41). HRV was worse in the post-COVID group when compared to the control group (p 

Open Access PDF

Concepts Keywords
10min Adult
Cardiac Aged
Hospitalization Autonomic Nervous System
Nitric Biomarkers
Pcr Biomarkers
Blood plasma lipids
Cholesterol
Cholesterol
Cholesterol, HDL
Cholesterol, HDL
COVID-19
COVID-19
Cross-Sectional Studies
Female
Heart Rate
Heart rate variability
Humans
Male
Middle Aged
Nitric Oxide
Nitric Oxide
Nitric oxide
SARS-CoV-2
Triglycerides
Triglycerides

Original Article

(Visited 2 times, 1 visits today)